VitaCholine Ingredients Now Non-GMO Project Verified
Balchem Corp. said that its VitaCholine line of choline chloride and choline bitartrate ingredients have been verified non-GMO by the Non-GMO Project.
Photo © iStockphoto.com/mipan
Balchem Corp. (New Hampton, NY) announced that its VitaCholine line of choline chloride and choline bitartrate ingredients have been verified non-GMO by the Non-GMO Project. VitaCholine ingredients target a range of health categories, including prenatal care, cardiovascular health, memory, energy, and more.
In a press release from Balchem, Tom Druke, director, VitaCholine brand development, Balchem Human Nutrition and Pharma, explained that the new verification will help meet consumer demand for independently verified ingredients stateside, as well as boost the company’s sales efforts overseas. Said Druke: “When consumers purchase a product containing VitaCholine, these certifications are a mark of our high quality, safety, and transparency in manufacturing. And with 60 countries around the world having restrictions or bans on GMO products, this facilitates our international sales efforts.”
In the press statement, Balchem stated that third-party verification is increasingly important to consumers and industry alike, as it certifies that a product has been thoroughly evaluated for compliance with standards developed by industry experts and stakeholders. In addition, third-party verification is an “important mark of quality for product labeling.”
Courtney Pineau, associate director, the Non-GMO Project, added: “The Non-GMO Project celebrates Balchem's achievements in verifying a variety of its products and their commitment to providing consumers a transparent choice in the marketplace.”
Balchem added that in addition to the Non-GMO Project verification, it also participates in the USP Dietary Ingredient Verification Program. That program includes GMP facility auditing, ingredient quality control, and manufacturing documentation review. More information about the company’s third-party certifications can be found on its website.
Also read:
National Institutes of Health Awards Grant to Assess Choline Status
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
